[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343889-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-343889-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","wwp1-targeting-pten-for-polyubiquitination-to-promote-bone-metastasis-of-luminal-breast-cancer","WWP1 targeting PTEN for polyubiquitination to promote bone metastasis of luminal breast cancer","","Luminal breast cancer frequently relapses in bone after distant spread, yet the molecular basis for its organotropism remains unclear. This study evaluates how WWP1 (an E3 ubiquitin ligase) interacts with PTEN to control bone tropism. WWP1 is overexpressed in luminal breast cancer tissues and correlates with poor patient prognosis. In cancer cells, WWP1 mediates PTEN ubiquitination, causing functional PTEN loss. These findings link WWP1-driven PTEN polyubiquitination to early bone metastasis and suggest a therapeutic strategy to mitigate skeletal dissemination.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/wwp1-targeting-pten-for-polyubiquitination-to-promote-bone-metastasis-of-luminal-breast-cancer/343889/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/wwp1-targeting-pten-for-polyubiquitination-to-promote-bone-metastasis-of-luminal-breast-cancer/343889.png","ImageObject",300,407,{"name":42,"@type":43},"Seraphina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-09","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main aim of the study on WWP1 and PTEN?","Question",{"text":63,"@type":64},"To determine the role of the WWP1-PTEN interaction in driving bone tropism in luminal breast cancer and clarify the underlying mechanisms.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does WWP1 affect PTEN in luminal breast cancer cells?",{"text":68,"@type":64},"WWP1 mediates PTEN ubiquitination, leading to functional loss of PTEN in luminal breast cancer cells.",{"name":70,"@type":61,"acceptedAnswer":71},"What relationship did the study find between WWP1 and clinical outcomes?",{"text":72,"@type":64},"WWP1 was overexpressed in luminal breast cancer tissues and associated with poor prognosis in breast cancer patients.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343889,1790314712,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nWWP1 targeting PTEN for polyubiquitination to promote bone metastasis of luminal breast cancer  \nHao Jiang, Zhenxi Li, Wei Xu & Jianru Xiao􀀍  \nLuminal breast cancer exhibits a high incidence of bone recurrence when metastasizing to distant organs. The mechanisms underlying the organotropism of luminal breast cancer cells remain unclear. In this study, we aimed to determine the role ofWWP1 (WW domain-containing E3 ubiquitin protein ligase 1)-PTEN (phosphatase and tensin homolog deleted on chromosome ten) interaction in bone tropism in luminal breast cancer. We observed that WWP1 was overexpressed in luminal breast cancer tissues and associated with poor prognosis in breast cancer patients. In luminal breast cancer cells, WWP1 was found to mediate PTEN ubiquitination, resulting in the functional loss of PTEN. As a result, we demonstrate that WWP1 contributes to bone tropism in luminal breast cancer cells via the polyubiquitination of PTEN. Consequently, WWP1-mediated PTEN polyubiquitination contributed to the early metastasis of luminal breast cancer cells to the bone. Thus, our study provides a mechanistic insight into the bone tropism of luminal breast cancer cells and proposes a potential therapeutic strategy for mitigating cancer metastasis to the bone.  \nKeywords WWP1, PTEN, Luminal breast cancer, Bone metastasis, Ubiquitination  \nThe bone is the most common site of metastasis in breast cancer, particularly in the luminal subtype1,2. Over two-thirds of breast cancer patients develop bone metastasis, resulting in severe pain, pathological fractures, and other skeletal-related events, which are associated with poor prognosis for breast cancer patients3. Clinical studies have revealed that luminal breast cancer is more likely to metastasize to the bone than to the non-bone organs4,5. However, the molecular mechanisms that regulate this bone selectivity remain unclear. Intricate molecular interactions within cancer cells, which are highly context-dependent, contribute to the development of bone metastasis6. In particular, phosphatase and tension homolog deleted on chromosome ten (PTEN) is a significant tumor suppressor that cancer cells cannot afford to lose entirely before maturation7. By antagonizing the PI3K (phosphatidylinositol 3-kinase)/AKT (protein kinase B) signaling pathway, PTEN can govern fundamental cellular processes in various cancer cells8. Mice with PTEN overexpression have achieved a tumor-suppressive metabolic state, leading to a lifespan extension7. Therefore, the active and reactive functions of PTEN are considered promising therapeutic opportunities for human health. In terms of molecular mechanisms, the activity, expression, and localization of PTEN are frequently dysregulated through post-translational modifications, such as ubiquitylation9. The ubiquitylation of PTEN can be promoted by several E3 ubiquitin ligases, affecting its protein stability or dimer formation, both of which are highly consequential for tumor initiation, progression, and metastasis10–14. Post-translational modification is a complex process influenced by various molecules within different cells, so ubiquitylation is context-dependent15. Various evidence has demonstrated the critical role of PTEN post-translational modification in bone metastases, as well as lung, breast, and prostate cancer16.  \nSeveral E3 ubiquitin ligases have been reported to promote PTEN polyubiquitylation for degradation10, 13. However, WW domain-containing E3 ubiquitin protein ligase 1 (WWP1) was found to regulate PTEN dimerization and membrane recruitment, rather than degradation, through K27-linked polyubiquitinationin prostate cancer cells8. WWP1 belongs to the NEDD4 (neural precursor cell expressed, developmentally down-regulated 4) -like protein family, characterized by an N-terminal C2 domain, four WW domains, anda C-terminal catalytic HECT (homologous to the E6-associated pro","cbCaijzfxPp8eowG","https://ap.wps.com/l/cbCaijzfxPp8eowG","pdf",2278655,12,"English","# Background\n## PTEN function and post-translational dysregulation\n## PTEN ubiquitination and E3 ligase regulation\n# Study Rationale\n## Lack of evidence on WWP1-PTEN interaction in luminal subtype\n# Study Findings\n## WWP1 overexpression and prognosis\n## WWP1-mediated PTEN ubiquitination and polyubiquitination","[{\"question\":\"What is the main aim of the study on WWP1 and PTEN?\",\"answer\":\"To determine the role of the WWP1-PTEN interaction in driving bone tropism in luminal breast cancer and clarify the underlying mechanisms.\"},{\"question\":\"How does WWP1 affect PTEN in luminal breast cancer cells?\",\"answer\":\"WWP1 mediates PTEN ubiquitination, leading to functional loss of PTEN in luminal breast cancer cells.\"},{\"question\":\"What relationship did the study find between WWP1 and clinical outcomes?\",\"answer\":\"WWP1 was overexpressed in luminal breast cancer tissues and associated with poor prognosis in breast cancer patients.\"}]","WWP1 targeting PTEN for polyubiquitination to promote bone metastasis of luminal breast cancer | PDF",1790052396,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e00e8b5c5ffa0185d67a698f1014b949.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c800d04cd468ae0e23432c078ae2461b.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b0a2d5875504da4469f8aa798bfae8ad.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/951b2dfde743abc1738c984fc9ec9ee7.webp",980,1287]